| [1] |
Shiga Y, Nishida T, Jeoung JW, et al. Optical coherence tomography and optical coherence tomography angiography: Essential tools for detecting glaucoma and disease progression[J]. Front Ophthalmol (Lausanne), 2023, 3：1217125.
|
| [2] |
Dias MS, Luo X, Ribas VT, et al. The role of axonal transport in glaucoma[J]. Int J Mol Sci, 2022, 23(7): 3935.
|
| [3] |
Kurysheva NI. Assessment of the optic nerve head, peripapillary, and macular microcirculation in the newly diagnosed patients with primary open-angle glaucoma treated with topical tafluprost and tafluprost/timolol fixed combination[J]. Taiwan J Ophthalmol, 2019, 9(2): 93-99.
|
| [4] |
Ramkumar HL, Verma R, Ferreyra HA, et al. Myelinated retinal nerve fiber layer (RNFL): A comprehensive review[J]. Int Ophthalmol Clin, 2018, 58(4): 147-156.
|
| [5] |
Teixeira F, Fonseca AC, Pinto F. Acquired and progressive myelinated retinal nerve fibers in neurofibromatosis type 1[J]. J AAPOS, 2019, 23(3): 178-179.
|
| [6] |
Williams AJ, Fekrat S. Disappearance of myelinated retinal nerve fibers after pars plana vitrectomy[J]. Am J Ophthalmol, 2006, 142(3): 521-523.
|
| [7] |
Stassart RM, Möbius W, Nave KA, et al. The axon-myelin unit in development and degenerative disease[J]. Front Neurosci, 2018, 12(7): 467.
|
| [8] |
Suminaite D, Lyons DA, Livesey MR. Myelinated axon physiology and regulation of neural circuit function[J]. Glia, 2019, 67(11): 2050-2062.
|
| [9] |
Noori R, Park D, Griffiths JD, et al. Activity-dependent myelination: A glial mechanism of oscillatory self-organization in large-scale brain networks[J]. Proc Natl Acad Sci U S A, 2020, 117(24): 13227-13237.
|
| [10] |
Araújo SES, Mendonça HR, Wheeler NA, et al. Inflammatory demyelination alters subcortical visual circuits[J]. J Neuroinflammation, 2017, 14(1): 162.
|
| [11] |
Son JL, Soto I, Oglesby E, et al. Glaucomatous optic nerve injury involves early astrocyte reactivity and late oligodendrocyte loss[J]. Glia, 2010, 58(7): 780-789.
|
| [12] |
Reinehr S, Reinhard J, Gandej M, et al. Simultaneous complement response via lectin pathway in retina and optic nerve in an experimental autoimmune glaucoma model[J]. Front Cell Neurosci, 2016, 10(2): 140.
|
| [13] |
Kuehn S, Meißner W, Grotegut P, et al. Intravitreal S100B injection leads to progressive glaucoma like damage in retina and optic nerve[J]. Front Cell Neurosci, 2018, 12(3): 312.
|
| [14] |
Kuehn S, Rodust C, Stute G, et al. Concentration-dependent inner retina layer damage and optic nerve degeneration in a NMDA Model[J]. J Mol Neurosci, 2017, 63(3-4): 283-299.
|
| [15] |
Kimura A, Namekata K, Guo X, et al. Targeting oxidative stress for treatment of glaucoma and optic neuritis[J]. Oxid Med Cell Longev, 2017: 2817252.
|
| [16] |
Coughlin L, Morrison RS, Horner PJ, et al. Mitochondrial morphology differences and mitophagy deficit in murine glaucomatous optic nerve[J]. Invest Ophthalmol Vis Sci, 2015, 56(3): 1437-1446.
|
| [17] |
Smith MA, Plyler ES, Dengler-Crish CM, et al. Nodes of Ranvier in glaucoma[J]. Neuroscience, 2018, 390(10): 104-118.
|
| [18] |
Parisi V, Ziccardi L, Tanga L, et al. Neural conduction along postretinal visual pathways in glaucoma[J]. Front Aging Neurosci, 2021, 13: 697425.
|
| [19] |
Hanekamp S, Ĉurĉiĉ-Blake B, Caron B, et al. White matter alterations in glaucoma and monocular blindness differ outside the visual system[J]. Sci Rep, 2021, 11(1): 6866.
|
| [20] |
Nucci C, Garaci F, Altobelli S, et al. Diffusional kurtosis imaging of white matter degeneration in glaucoma[J]. J Clin Med, 2020, 9(10): 3122.
|
| [21] |
Jiang F, Zeng FF, Yu C, et al. Altered whole-brain gray matter volume in primary angle closure glaucoma patients: a voxel-based morphometry study[J]. Neuroreport, 2018, 29(16): 1405-1412.
|
| [22] |
Ong YT, Hilal S, Cheung CY, et al. Retinal neurodegeneration on optical coherence tomography and cerebral atrophy[J]. Neurosci Lett, 2015, 584(1): 12-16.
|
| [23] |
Frezzotti P, Giorgio A, Toto F, et al. Early changes of brain connectivity in primary open angle glaucoma[J]. Hum Brain Mapp, 2016, 37(12): 4581-4596.
|
| [24] |
Chan RW, Won Bang J, Trivedi V, et al. Relationships between cerebrovascular reactivity, visual-evoked functional activity, and resting-state functional connectivity in the visual cortex and basal forebrain in glaucoma[J]. Annu Int Conf IEEE Eng Med Biol Soc, 2021, 2021(11): 4037-4040.
|
| [25] |
Baumann N, Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system[J]. Physiol Rev, 2001, 81(2): 871-927.
|
| [26] |
You Y, Joseph C, Wang C, et al. Demyelination precedes axonal loss in the transneuronal spread of human neurodegenerative disease[J]. Brain, 2019, 142(2): 426-442.
|
| [27] |
Franklin RJM, Ffrench-Constant C. Regenerating CNS myelin - from mechanisms to experimental medicines[J]. Nat Rev Neurosci, 2017, 18(12): 753-769.
|
| [28] |
Ambrosius W, Michalak S, Kozubski W, et al. Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management[J]. Int J Mol Sci, 2020, 22(1): 100.
|
| [29] |
Madsen PM, Pinto M, Patel S, et al. Mitochondrial DNA double-strand breaks in oligodendrocytes cause demyelination, axonal injury, and CNS inflammation[J]. J Neurosci, 2017, 37(42): 10185-10199.
|
| [30] |
Minchenberg SB, Massa PT. The control of oligodendrocyte bioenergetics by interferon-gamma (IFN-γ) and Src homology region 2 domain-containing phosphatase-1 (SHP-1) [J]. J Neuroimmunol, 2019, 331: 46-57.
|
| [31] |
Luo F, Herrup K, Qi X, et al. Inhibition of Drp1 hyper-activation is protective in animal models of experimental multiple sclerosis[J]. Exp Neurol, 2017, 292: 21-34.
|
| [32] |
Balabanov R, Strand K, Goswami R, et al. Interferon-gamma-oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis[J]. J Neurosci, 2007, 27(8): 2013-2024.
|
| [33] |
Kunkl M, Frascolla S, Amormino C, et al. T helper cells: the modulators of inflammation in multiple sclerosis[J]. Cells, 2020, 9(2): 482.
|
| [34] |
Reinehr S, Reinhard J, Gandej M, et al. Simultaneous complement response via lectin pathway in retina and optic nerve in an experimental autoimmune glaucoma model[J]. Front Cell Neurosci, 2016, 10: 140.
|
| [35] |
Rose J, Brian C, Woods J, et al. Mitochondrial dysfunction in glial cells: Implications for neuronal homeostasis and survival[J]. Toxicology, 2017, 391(11): 109-115.
|
| [36] |
Philips T, Rothstein JD. Oligodendroglia: metabolic supporters of neurons[J]. J Clin Invest, 2017, 127(9): 3271-3280.
|
| [37] |
Kimura A, Namekata K, Guo X, et al. Targeting oxidative stress for treatment of glaucoma and optic Neuritis[J]. Oxid Med Cell Longev, 2017: 2817252.
|
| [38] |
Spaas J, van Veggel L, Schepers M, et al. Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders[J]. Cell Mol Life Sci, 2021, 78(10): 4615-4637.
|
| [39] |
Kamińska J, Koper OM, Piechal K, et al. Multiple sclerosis-etiology and diagnostic potential[J]. Postepy Hig Med Dosw (Online), 2017, 71(6): 551-563.
|
| [40] |
Hor JY, Asgari N, Nakashima I, et al. Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide[J]. Front Neurol, 2020, 11(6): 501.
|
| [41] |
Huda S, Whittam D, Bhojak M, et al. Neuromyelitis optica spectrum disorders[J]. Clin Med (Lond), 2019, 19(2): 169-176.
|
| [42] |
Calabrese M, Magliozzi R, Ciccarelli O, et al. Exploring the origins of grey matter damage in multiple sclerosis[J]. Nat Rev Neurosci, 2015, 16(3): 147-158.
|
| [43] |
Araújo SES, Mendonça HR, Wheeler NA, et al. Inflammatory demyelination alters subcortical visual circuits[J]. J Neuroinflammation, 2017, 14(1): 162.
|
| [44] |
Di Pauli F, Berger T. Myelin oligodendrocyte glycoprotein antibody-associated disorders: toward a new spectrum of inflammatory demyelinating CNS disorders[J]Front Immunol, 2018, 9: 2753.
|
| [45] |
Jarius S, Wildemann B, Paul F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment[J]. Clin Exp Immunol, 2014, 176(2): 149-164.
|
| [46] |
Raffaele S, Boccazzi M, Fumagalli M. Oligodendrocyte dysfunction in amyotrophic lateral sclerosis: mechanisms and therapeutic perspectives[J]. Cells, 2021, 10(3): 565.
|
| [47] |
Traiffort E, Morisset-Lopez S, Moussaed M, et al. Defective oligodendroglial lineage and demyelination in amyotrophic lateral sclerosis[J]. Int J Mol Sci, 2021, 22(7): 3426.
|
| [48] |
Mitew S, Kirkcaldie MT, Halliday GM, et al. Focal demyelination in Alzheimer's disease and transgenic mouse models[J]. Acta Neuropathol, 2010, 119(5): 567-577.
|
| [49] |
Budde MD, Kim JH, Liang HF, et al. Toward accurate diagnosis of white matter pathology using diffusion tensor imaging[J]. Magn Reson Med, 2007, 57(4): 688-695.
|
| [50] |
Schmierer K, Wheeler-Kingshott CA, Boulby PA, et al. Diffusion tensor imaging of post mortem multiple sclerosis brain[J]. Neuroimage, 2007, 35(2): 467-477.
|
| [51] |
Zhang QJ, Wang D, Bai ZL, et al. Diffusion tensor imaging of optic nerve and optic radiation in primary chronic angle-closure glaucoma using 3T magnetic resonance imaging[J]. Int J Ophthalmol, 2015, 18; 8(5): 975-979.
|
| [52] |
Ashtari F, Ataei A, Kafieh R, et al. Optical coherence tomography in neuromyelitis optica spectrum disorder and multiple sclerosis: A population-based study[J]. Mult Scler Relat Disord, 2021, 47: 102625.
|
| [53] |
Oertel FC, Zimmermann H, Paul F, et al. Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy[J]. EPMA J, 2017, 9(1): 21-33.
|
| [54] |
Brandt AU, Specovius S, Oberwahrenbrock T, et al. Frequent retinal ganglion cell damage after acute optic neuritis[J]. Mult Scler Relat Disord, 2018, 22: 141-147.
|
| [55] |
Cordano C, Nourbakhsh B, Devereux M, et al. pRNFL as a marker of disability worsening in the medium/long term in patients with MS[J]. Neurol Neuroimmunol Neuroinflamm, 2018, 6(2): e533.
|
| [56] |
Knier B, Berthele A, Buck D, et al. Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination[J]. Mult Scler, 2016, 22(7): 893-900.
|
| [57] |
Cellerino M, Cordano C, Boffa G, et al. Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS[J]. Neurol Neuroimmunol Neuroinflamm, 2019, 6(5): e596.
|
| [58] |
Martinez-Lapiscina EH, Arnow S, Wilson JA, et al. IMSVISUAL consortium. Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study[J]. Lancet Neurol, 2016, 15(6): 574-584.
|
| [59] |
Oberwahrenbrock T, Schippling S, Ringelstein M, et al. Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography[J]. Mult Scler Int, 2012: 530305.
|
| [60] |
Stiebel-Kalish H, Hellmann MA, Mimouni M, et al. Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis[J]Neurol Neuroimmunol Neuroinflamm, 2019, 6(4): e572.
|
| [61] |
Wostyn P. Are generalized reduced cerebrospinal fluid dynamics and optic nerve sheath compartmentation sequential steps in the pathogenesis of normal-tension glaucoma[J]Eye Brain, 2021, 13: 129-130.
|
| [62] |
Hua Y, Voorhees AP, Sigal IA. Cerebrospinal fluid pressure: revisiting factors influencing optic nerve head biomechanics[J]. Invest Ophthalmol Vis Sci, 2018, 59(1): 154-165.
|
| [63] |
Zhang HJ, Mi XS, So KF. Normal tension glaucoma: from the brain to the eye or the inverse[J]Neural Regen Res, 2019, 14(11): 1845-1850.
|
| [64] |
Stadelmann C, Timmler S, Barrantes-Freer A, et al. Myelin in the central nervous system: structure, function, and pathology[J]. Physiol Rev, 2019, 99(3): 1381-1431.
|
| [65] |
Kong L, Valdivia DO, Simon CM, et al. Impaired prenatal motor axon development necessitates early therapeutic intervention in severe SMA[J]. Sci Transl Med, 2021, 13(578): eabb6871.
|
| [66] |
Yazdankhah M, Ghosh S, Shang P, et al. BNIP3L-mediated mitophagy is required for mitochondrial remodeling during the differentiation of optic nerve oligodendrocytes[J]. Autophagy, 2021, 17(10): 3140-3159.
|